EUVIMEDEUVIMED entdecken
Crossref

Comparative Efficacy of Levonorgestrel-Releasing Intrauterine System versus Oral Norethisterone in the Management of Idiopathic Menorrhagia: A Prospective Comparative Study

Rajkumari Meena, Radha Kumari, Indu Rekha DungDung, Payal Boipai, Anjali Kachhap, Kiran Kumari

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Rajkumari Meena und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Idiopathic menorrhagia is a prevalent gynecological condition characterized by excessive menstrual blood loss without regular structural or organic pelvic pathology. It severely disrupts systemic quality of life and leads to progressive iron deficiency anemia. Levonorgestrel-releasing intrauterine system (LNG-IUS) and oral cyclical norethisterone represent two distinct standard medical approaches requiring structured comparative verification.

Objective

To evaluate and compare the therapeutic efficacy, safety parameters, and overall patient acceptability of LNG-IUS versus oral norethisterone in women suffering from idiopathic menorrhagia. Materials and Methods: This prospective comparative study spanned an 18-month duration at the Department of Obstetrics and Gynecology, RIMS, Ranchi. Sixty-four reproductive-age females diagnosed with idiopathic menorrhagia were recruited based on explicit criteria and assigned to two equal intervention groups (n=32 per arm). Group A received the intrauterine insertion of an LNG-IUS (Mirena, 52 mg), while Group B was treated with oral Norethisterone tablets (5 mg three times daily from Day 1 to Day 21 of each cycle) for 6 sequential cycles. Serial clinical follow-ups were carried out at 1, 3, and 6 months. Primary outcomes included change in menstrual blood loss quantified via the Pictorial Blood Assessment Chart (PBAC) scores and hemoglobin (Hb) levels. Secondary indices included transvaginal ultrasound assessment of endometrial thickness, intervention failure rates necessitating hysterectomy, and absolute patient satisfaction scores.

Results

Baseline parameters were homogenous across both cohorts. Pre-treatment mean PBAC scores were statistically similar (LNG-IUS: 470.34±51.00 vs Norethisterone: 478.59±55.93, p=0.540). At the 6-month review, the LNG-IUS cohort exhibited an extensive decline in mean PBAC scores to 54.13±11.42, which was significantly lower than the 139.09±110.76 recorded in the norethisterone group (p

Zitieren

APA

Meena, R., Kumari, R., DungDung, I. R., Boipai, P., Kachhap, A., & Kumari, K. (2026). Comparative Efficacy of Levonorgestrel-Releasing Intrauterine System versus Oral Norethisterone in the Management of Idiopathic Menorrhagia: A Prospective Comparative Study. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.118

Vancouver

Meena R, Kumari R, DungDung IR, Boipai P, Kachhap A, Kumari K. Comparative Efficacy of Levonorgestrel-Releasing Intrauterine System versus Oral Norethisterone in the Management of Idiopathic Menorrhagia: A Prospective Comparative Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.118

BibTeX
@article{Meena2026,
  author = {Meena, Rajkumari and Kumari, Radha and DungDung, Indu Rekha and Boipai, Payal and Kachhap, Anjali and Kumari, Kiran},
  title = {Comparative Efficacy of Levonorgestrel-Releasing Intrauterine System versus Oral Norethisterone in the Management of Idiopathic Menorrhagia: A Prospective Comparative Study},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.118}
}
Kostenlos starten →